title: The prevalence of chromosomal deletions relating to developmental delay and/or intellectual disability in human euploid blastocysts.
abstract: Chromosomal anomalies in human embryos produced by in vitro fertilization are very common, which include numerical (aneuploidy) and structural (deletion, duplication or others) anomalies. Our previous study indicated that chromosomal deletion(s) is the most common structural anomaly accounting for approximately 8% of euploid blastocysts. It is still unknown if these deletions in human euploid blastocysts have clinical significance. In this study, we analyzed 15 previously diagnosed euploid blastocysts that had chromosomal deletion(s) using Agilent oligonucleotide DNA microarray platform and localized the gene location in each deletion. Then, we used OMIM gene map and phenotype database to investigate if these deletions are related with some important genes that cause genetic diseases, especially developmental delay or intellectual disability. As results, we found that the detectable chromosomal deletion size with Agilent microarray is above 2.38 Mb, while the deletions observed in human blastocysts are between 11.6 to 103 Mb. With OMIM gene map and phenotype database information, we found that deletions can result in loss of 81-464 genes. Out of these genes, 34-149 genes are related with known genetic problems. Furthermore, we found that 5 out of 15 samples lost genes in the deleted region, which were related to developmental delay and/or intellectual disability. In conclusion, our data indicates that all human euploid blastocysts with chromosomal deletion(s) are abnormal and transfer of these embryos may cause birth defects and/or developmental and intellectual disabilities. Therefore, the embryos with chromosomal deletion revealed by DNA microarray should not be transferred to the patients, or further gene map and/or phenotype seeking is necessary before making a final decision.
authors.affiliation: Key Laboratory of Major Obstetrics Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangdong, China.
authors.forename: Wenyin
authors.initials: W
authors.lastname: He
authors.affiliation: Key Laboratory of Major Obstetrics Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangdong, China.
authors.forename: Xiaofang
authors.initials: X
authors.lastname: Sun
authors.affiliation: Pacgenomics Inc., Village Medical Center, Thousand Oaks, California, United States of America.
authors.forename: Lian
authors.initials: L
authors.lastname: Liu
authors.affiliation: Pacgenomics Inc., Village Medical Center, Thousand Oaks, California, United States of America.
authors.forename: Man
authors.initials: M
authors.lastname: Li
authors.affiliation: Pacgenomics Inc., Village Medical Center, Thousand Oaks, California, United States of America.
authors.forename: Hua
authors.initials: H
authors.lastname: Jin
authors.affiliation: New Houston Health, Houston, Texas, United States of America ; Vivere Health, Franklin, Tennessee, United States of America.
authors.forename: Wei-Hua
authors.initials: WH
authors.lastname: Wang
mesh_terms: D000782:Aneuploidy; D001755:Blastocyst / Q000378:metabolism*; D002872:Chromosome Deletion; D002874:Chromosome Mapping; D055028:Comparative Genomic Hybridization; D002658:Developmental Disabilities / Q000175:diagnosis / Q000235:genetics*; D005820:Genetic Testing; D006801:Humans; D008607:Intellectual Disability / Q000175:diagnosis / Q000235:genetics*; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods; D010641:Phenotype; D019836:Preimplantation Diagnosis